Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Wyeth Pharmaceuticals

Facebook Twitter LinkedIn Email Comments
Wyeth Pharmaceuticals of Madison, N.J., has agreed to use an imaging agent produced by Siemens Medical Solutions of Hoffman Estates, Ill., in clinical studies of Alzheimer’s disease therapies. When used with PET, the agent can aid in the identification of Alzheimer’s-related amyloid plaques and neuronal tangles in the brain.

BioPhotonics
Apr 2007
Biophotonicsimagingneuronal tanglesNews & FeaturesWyeth Pharmaceuticals

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.